197 related articles for article (PubMed ID: 34395521)
1. Identification of a Gene Set Correlated With Immune Status in Ovarian Cancer by Transcriptome-Wide Data Mining.
Fan L; Lei H; Lin Y; Zhou Z; Shu G; Yan Z; Chen H; Zhang T; Yin G
Front Mol Biosci; 2021; 8():670666. PubMed ID: 34395521
[TBL] [Abstract][Full Text] [Related]
2. RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer.
Xie B; Tan G; Ren J; Lu W; Pervaz S; Ren X; Otoo AA; Tang J; Li F; Wang Y; Wang M
Front Oncol; 2022; 12():830908. PubMed ID: 35299734
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer.
Yu J; Liu TT; Liang LL; Liu J; Cai HQ; Zeng J; Wang TT; Li J; Xiu L; Li N; Wu LY
Cancer Cell Int; 2021 Jul; 21(1):353. PubMed ID: 34229669
[TBL] [Abstract][Full Text] [Related]
4. Identification of hub genes and compounds controlling ovarian cancer stem cell characteristics via stemness indices analysis.
Wang Z; Wu D; Xia Y; Yang B; Xu T
Ann Transl Med; 2021 Mar; 9(5):379. PubMed ID: 33842600
[TBL] [Abstract][Full Text] [Related]
5. Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.
Kang K; Xie F; Mao J; Bai Y; Wang X
Front Oncol; 2020; 10():573141. PubMed ID: 33072607
[No Abstract] [Full Text] [Related]
6. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
[TBL] [Abstract][Full Text] [Related]
7. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
8. An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer.
Zhu K; Ma J; Tian Y; Liu Q; Zhang J
BMC Womens Health; 2024 Jan; 24(1):49. PubMed ID: 38238671
[TBL] [Abstract][Full Text] [Related]
9. Association between tumor mutation burden and immune infiltration in ovarian cancer.
Fan S; Gao X; Qin Q; Li H; Yuan Z; Zhao S
Int Immunopharmacol; 2020 Dec; 89(Pt A):107126. PubMed ID: 33189611
[TBL] [Abstract][Full Text] [Related]
10. Gene expression and immune infiltration in melanoma patients with different mutation burden.
Wang L; Chen F; Liu R; Shi L; Zhao G; Yan Z
BMC Cancer; 2021 Apr; 21(1):379. PubMed ID: 33836680
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of prognostic immune-related genes in the tumor microenvironment of ovarian cancer.
Wang J; Su X; Wang C; Xu M
Ann Transl Med; 2022 Jan; 10(2):91. PubMed ID: 35282097
[TBL] [Abstract][Full Text] [Related]
12. Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model.
Liang L; Yu J; Li J; Li N; Liu J; Xiu L; Zeng J; Wang T; Wu L
Front Oncol; 2021; 11():711020. PubMed ID: 34621670
[TBL] [Abstract][Full Text] [Related]
13. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
14. Classification of Lung Adenocarcinoma Based on Immune Checkpoint and Screening of Related Genes.
Zhou T; Yang P; Tang S; Zhu Z; Li X; Yang Z; Wu R; Tian X; Li L
J Oncol; 2021; 2021():5512325. PubMed ID: 34367284
[TBL] [Abstract][Full Text] [Related]
15. Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.
Lei J; He ZY; Wang J; Hu M; Zhou P; Lian CL; Hua L; Wu SG; Zhou J
Cancer Med; 2021 Apr; 10(8):2924-2939. PubMed ID: 33742531
[TBL] [Abstract][Full Text] [Related]
16. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
[No Abstract] [Full Text] [Related]
17. Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis.
Liang Y; Zhang C; Dai DQ
World J Gastroenterol; 2019 Jul; 25(26):3392-3407. PubMed ID: 31341364
[TBL] [Abstract][Full Text] [Related]
18. The Prognosis and Immune Checkpoint Blockade Efficacy Prediction of Tumor-Infiltrating Immune Cells in Lung Cancer.
Liu X; Shang X; Li J; Zhang S
Front Cell Dev Biol; 2021; 9():707143. PubMed ID: 34422829
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Molecule PLA2G2D Is a Potential Prognostic Biomarker Correlating With Immune Cell Infiltration and the Expression of Immune Checkpoint Genes in Cervical Squamous Cell Carcinoma.
Liu H; Xu R; Gao C; Zhu T; Liu L; Yang Y; Zeng H; Huang Y; Wang H
Front Oncol; 2021; 11():755668. PubMed ID: 34733790
[TBL] [Abstract][Full Text] [Related]
20. Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma.
Xu Q; Xu H; Deng R; Wang Z; Li N; Qi Z; Zhao J; Huang W
Cancer Cell Int; 2021 Jul; 21(1):342. PubMed ID: 34217320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
